2 Blue Chip Dividends Getting Way Too Cheap

08:45am, Monday, 15'th Nov 2021
Buying above-average companies at below-average prices is a winning strategy.
Bristol Myers Squibb & Co (NYSE: BMY) has announced long-term data from a mavacamten study acquired via a $13 billion MyoKardia buyout.  Heart patients who received mavacamten in a cohort of the l
Thomasville National Bank lifted its holdings in Bristol-Myers Squibb (NYSE:BMY) by 2.9% during the 3rd quarter, according to the company in its most recent Form 13F filing with the SEC. The firm owned 95,336 shares of the biopharmaceutical companys stock after buying an additional 2,697 shares during the quarter. Thomasville National Banks holdings in Bristol-Myers []
Park National Corp OH lowered its position in shares of Bristol-Myers Squibb (NYSE:BMY) by 5.8% in the third quarter, HoldingsChannel reports. The fund owned 29,919 shares of the biopharmaceutical companys stock after selling 1,840 shares during the period. Park National Corp OHs holdings in Bristol-Myers Squibb were worth $1,770,000 at the end of the most []
Click to get the best stock tips daily for free!

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE